How many institutions held AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value in Q2 2019?

71 institutional investors reported AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value for Q2 2019. Use the holders table for investor-level position and value details.

Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH)

Q: What does CUSIP 05156V102 represent in this 13F holders report?

CUSIP 05156V102 is the security identifier for AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value used to aggregate holder disclosures.

CUSIP: 05156V102

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class: Equity / Common Shares, no par value
Shares outstanding: 132,929,348
Total 13F shares: 29,347,880
Share change: -477,460
Total reported value: $193,099,929
Put/Call ratio: 70%
Price per share: $6.58
Number of holders: 71
Value change: -$3,061,002
Number of buys: 24
Number of sells: 36

Quarterly Holders Quick Answers

What is CUSIP 05156V102?
CUSIP 05156V102 identifies AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2019
Previous quarter: Q1 2019

Recent filing periods for CUSIP 05156V102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
NEA Management Company, LLC	13F	Company	3.9%	5,172,683	$33,622,000	—	31 Mar 2019	13F
FMR LLC	13F	Company	3.4%	4,553,903	$29,601,000	—	31 Mar 2019	13F
Consonance Capital Management LP	13F	Company	3.2%	4,222,558	$27,447,000	—	31 Mar 2019	13F
Polar Capital LLP	13F	Company	2.5%	3,312,723	$21,533,000	—	31 Mar 2019	13F
ORBIMED ADVISORS LLC	13F	Company	2.4%	3,149,810	$20,474,000	—	31 Mar 2019	13F
FRANKLIN RESOURCES INC	13F	Company	1.2%	1,612,900	$10,484,000	—	31 Mar 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	1%	1,379,301	$8,965,000	—	31 Mar 2019	13F
Vivo Capital, LLC	13F	Company	0.91%	1,213,290	$7,886,000	—	31 Mar 2019	13F
BlackRock Finance, Inc.	13F	Company	0.67%	893,296	$5,807,000	—	31 Mar 2019	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.43%	569,162	$3,700,000	—	31 Mar 2019	13F
D. E. Shaw & Co., Inc.	13F	Company	0.41%	548,198	$3,564,000	—	31 Mar 2019	13F
Hudson Bay Capital Management LP	13F	Company	0.31%	412,500	$2,681,000	—	31 Mar 2019	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.27%	365,510	$2,376,000	—	31 Mar 2019	13F
Redmile Group, LLC	13F	Company	0.24%	323,265	$2,101,000	—	31 Mar 2019	13F
Creative Planning	13F	Company	0.16%	208,700	$1,357,000	—	31 Mar 2019	13F
IRONWOOD INVESTMENT MANAGEMENT LLC	13F	Company	0.14%	180,647	$1,174,000	—	31 Mar 2019	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.14%	179,700	$1,168,000	—	31 Mar 2019	13F
DEUTSCHE BANK AG\	13F	Company	0.13%	170,455	$1,107,000	—	31 Mar 2019	13F
S.c.a. Candriam	13F	Individual	0.12%	157,500	$1,024,000	—	31 Mar 2019	13F
CITADEL ADVISORS LLC	13F	Company	0.1%	136,519	$887,000	—	31 Mar 2019	13F
Swiss National Bank	13F	Company	0.07%	98,100	$637,000	—	31 Mar 2019	13F
Kazazian Asset Management, LLC	13F	Company	0.07%	97,056	$631,000	—	31 Mar 2019	13F
Rockefeller Capital Management L.P.	13F	Company	0.07%	91,585	$595,000	—	31 Mar 2019	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.06%	80,000	$520,000	—	31 Mar 2019	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.06%	73,424	$477,000	—	31 Mar 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.05%	64,985	$422,000	—	31 Mar 2019	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.04%	57,561	$374,000	—	31 Mar 2019	13F
David M. Knott	13F	Individual	0.04%	52,700	$343,000	—	31 Mar 2019	13F
STIFEL FINANCIAL CORP	13F	Company	0.03%	46,500	$303,000	—	31 Mar 2019	13F
Nicholas Investment Partners, LP	13F	Company	0.03%	39,845	$259,000	—	31 Mar 2019	13F
MORGAN STANLEY	13F	Company	0.02%	32,794	$214,000	—	31 Mar 2019	13F
ProShare Advisors LLC	13F	Company	0.02%	28,985	$188,000	—	31 Mar 2019	13F
Cubist Systematic Strategies, LLC	13F	Company	0.02%	28,100	$183,000	—	31 Mar 2019	13F
VANGUARD GROUP INC	13F	Company	0.02%	24,471	$159,000	—	31 Mar 2019	13F
CREDIT SUISSE AG/	13F	Company	0.02%	20,109	$130,000	—	31 Mar 2019	13F
BANK OF MONTREAL /CAN/	13F	Company	0.01%	18,158	$118,000	—	31 Mar 2019	13F
Dynamic Technology Lab Private Ltd	13F	Company	0.01%	15,279	$99,000	—	31 Mar 2019	13F
Patriot Financial Group Insurance Agency, LLC	13F	Company	0.01%	14,850	$97,000	—	31 Mar 2019	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.01%	13,830	$89,000	—	31 Mar 2019	13F
A.R.T. Advisors, LLC	13F	Company	0.01%	12,695	$83,000	—	31 Mar 2019	13F
MGO ONE SEVEN LLC	13F	Company	0.01%	11,000	$71,000	—	31 Mar 2019	13F
Spark Investment Management LLC	13F	Company	0.01%	11,000	$71,000	—	31 Mar 2019	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.01%	10,900	$71,000	—	31 Mar 2019	13F
Realta Investment Advisors	13F	Company	0.01%	10,739	$70,000	—	31 Mar 2019	13F
TORONTO DOMINION BANK	13F	Company	0.01%	9,769	$63,000	—	31 Mar 2019	13F
US BANCORP \DE\	13F	Company	0.01%	8,820	$57,000	—	31 Mar 2019	13F
UBS Group AG	13F	Company	0.01%	7,024	$46,000	—	31 Mar 2019	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.01%	6,904	$45,000	—	31 Mar 2019	13F
CANADA LIFE ASSURANCE Co	13F	Company	0.01%	6,730	$43,000	—	31 Mar 2019	13F
BROWN BROTHERS HARRIMAN & CO	13F	Company	0%	6,500	$42,000	—	31 Mar 2019	13F

Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q2 2019

As of 30 Jun 2019, Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) was held by 71 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 29,347,880 shares. The largest 10 holders included NEA Management Company, LLC, Consonance Capital Management LP, ORBIMED ADVISORS LLC, Polar Capital LLP, FMR LLC, Vivo Capital, LLC, FRANKLIN RESOURCES INC, GOLDMAN SACHS GROUP INC, ACUTA CAPITAL PARTNERS, LLC, and BlackRock Inc.. This page lists 71 institutional shareholders reporting positions in this security for the Q2 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2019 vs Q1 2019 Across Filers

Q1 2019 holders

Q2 2019 holders

Holder diff

-5

Investor	Q1 2019 Shares	Q2 2019 Shares	Share Diff	Share Chg %	Q1 2019 Value $	Q2 2019 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.